Anatomic site-specific proteomic signatures of gastrointestinal stromal tumors

Proteomics - Clinical Applications

Volumn 3, Issue 5, 2009, Pages 584-596

  Suehara, Yoshiyuki ^a,b,c   Kikuta, Kazutaka ^a,b,d   Nakayama, Robert ^a,b,d   Fujii, Kiyonaga ^a,e   Ichikawa, Hitoshi ^a   Shibata, Tatsuhiro ^a   Seki, Kunihiko ^b,f   Hasegawa, Tadashi ^b,g   Gotoh, Masahiro ^a   Tochigi, Naobumi ^a   Shimoda, Tadakazu ^b   Shimada, Yasuhiro ^b   Sano, Takeshi ^b   Beppu, Yasuo ^b   Kurosawa, Hisashi ^c   Hirohashi, Setsuo ^a   Kawai, Akira ^b   Kondo, Tadashi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f Japan Railway Tokyo General Hospital   (Japan)

^g SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 D DIGE; Anatomic site; Gastrointestinal stromal tumor; Proteomics

Indexed keywords

ALPHA ACTININ; MESSENGER RNA; PIGMENT EPITHELIUM DERIVED FACTOR; PROHIBITIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SMALL INTESTINE CANCER; STOMACH CANCER; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE; WESTERN BLOTTING;

EID: 67649438799     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800168     Document Type: Article

References (42)

1. Joensuu, H., Kindblom, L. G., Gastrointestinal stromal tumors - a review. Acta Orthop. Scand. Suppl. 2004, 75, 62-71.
2. Miettinen, M., El-Rifai, W., L, H. L. S., Lasota, J., Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum. Pathol. 2002, 33, 478-483.
3. Suehara, Y., Kondo, T., Seki, K., Shibata, T. et al., Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin. Cancer Res. 2008, 14, 1707-1717.
4. Emory, T. S., Sobin, L. H., Lukes, L., Lee, D. H., O'Leary, T. J., Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am. J. Surg. Pathol. 1999, 23, 82-87.
5. Fletcher, C. D., Berman, J. J., Corless, C., Gorstein, F. et al., Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int. J. Surg. Pathol. 2002, 10, 81-89.
6. Wozniak, A., Sciot, R., Guillou, L., Pauwels, P. et al., Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status. Genes Chromosomes Cancer 2007, 46, 261-276.
7. Antonescu, C. R., Viale, A., Sarran, L., Tschernyavsky, S. J. et al., Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin. Cancer Res. 2004, 10, 3282-3290.
8. Nishitani, A., Hirota, S., Nishida, T., Isozaki, K. et al., Differential expression of connexin 43 in gastrointestinal stromal tumours of gastric and small intestinal origin. J. Pathol. 2005, 206, 377-382.
9. Agaram, N., Wong, G., Guo, T., Maki, R. et al., Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer 2008, 47, 853-859.
10. Braconi, C., Bracci, R., Bearzi, I., Bianchi, F. et al., Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients. Ann. Oncol. 2008, 19, 1293-1298.
11. Stankey RH, L. A., Pathology and Genetics of Tumours of the Digestive System, IARC Press, Lyon 2000.
12. Hasegawa, T., Matsuno, Y., Shimoda, T., Hirohashi, S., Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum. Pathol. 2002, 33, 669-676.
13. Antonescu, C. R., Sommer, G., Sarran, L., Tschernyavsky, S. J. et al., Association of KITexon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin. Cancer Res. 2003, 9, 3329-3337.
14. Lasota, J., Jasinski, M., Sarlomo-Rikala, M., Miettinen, M., Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol. 1999, 154, 53-60.
15. Lasota, J., Dansonka-Mieszkowska, A., Stachura, T., Schneider-Stock, R. et al., Gastrointestinal stromal tumors with internal tandem duplications in 30 end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course. Mod. Pathol. 2003, 16, 1257-1264.
16. Nuell, M. J., Stewart, D. A., Walker, L., Friedman, V. et al., Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol. Cell. Biol. 1991, 11, 1372-1381.
17. Jang, J. S., Cho, H. Y., Lee, Y. J., Ha, W. S., Kim, H. W., The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol. Res. 2004, 14, 491-499.
18. He, Q. Y., Cheung, Y. H., Leung, S. Y., Yuen, S. T. et al., Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 2004, 4, 3276-3287.
19. Steele, F. R., Chader, G. J., Johnson, L. V., Tombran-Tink, J., Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. USA 1993, 90, 1526-1530.
20. Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E. et al., Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285, 245-248.
21. Maik-Rachline, G., Shaltiel, S., Seger, R., Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor. Blood 2005, 105, 670-678.
22. Doll, J. A., Stellmach, V. M., Bouck, N. P., Bergh, A. R. et al., Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat. Med. 2003, 9, 774-780.
23. Zhang, L., Chen, J., Ke, Y., Mansel, R. E., Jiang, W. G., Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Int. J. Mol. Med. 2006, 17, 937-944.
24. Cai, J., Parr, C., Watkins, G., Jiang, W. G., Boulton, M., Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin. Cancer Res. 2006, 12, 3510-3517.
25. Uehara, H., Miyamoto, M., Kato, K., Ebihara, Y. et al., Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res. 2004, 64, 3533-3537.
26. Sidle, D. M., Maddalozzo, J., Meier, J. D., Cornwell, M. et al., Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence. Arch. Otolaryngol. Head Neck Surg. 2005, 131, 990-995.
27. Cheung, L. W., Au, S. C., Cheung, A. N., Ngan, H. Y. et al., Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology 2006, 147, 4179-4191.
28. Hase, R., Miyamoto, M., Uehara, H., Kadoya, M. et al., Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin. Cancer Res. 2005, 11, 8737-8744.
29. Ek, E. T., Dass, C. R., Contreras, K. G., Choong, P. F., Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Ther. 2007.
30. Ek, E. T., Dass, C. R., Contreras, K. G., Choong, P. F., Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin. Exp. Metastasis 2007, 24, 93-106.
31. Streck, C. J., Zhang, Y., Zhou, J., Ng, C. et al., Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. J. Pediatr. Surg. 2005, 40, 236-243.
32. Garcia, M., Fernandez-Garcia, N. I., Rivas, V., Carretero, M. et al., Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res. 2004, 64, 5632-5642.
33. Matsumoto, K., Ishikawa, H., Nishimura, D., Hamasaki, K. et al., Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 2004, 40, 252-259.
34. Hara, T., Honda, K., Shitashige, M., Ono, M. et al., Mass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells. Mol. Cell. Proteomics 2007, 6, 479-491.
35. Hatakeyama, H., Kondo, T., Fujii, K., Nakanishi, Y. et al., Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 2006, 6, 6300-6316.
36. Honda, K., Yamada, T., Hayashida, Y., Idogawa, M. et al., Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 2005, 128, 51-62.
37. Yamagata, N., Shyr, Y., Yanagisawa, K., Edgerton, M. et al., A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin. Cancer Res. 2003, 9, 4695-4704.
38. Menez, J., Le Maux Chansac, B., Dorothee, G., Vergnon, I. et al., Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma. Oncogene 2004, 23, 2630-2639.
39. Honda, K., Yamada, T., Endo, R., Ino, Y. et al., Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J. Cell. Biol. 1998, 140, 1383-1393.
40. Corless, C. L., Fletcher, J. A., Heinrich, M. C., Biology of gastrointestinal stromal tumors. J. Clin. Oncol. 2004, 22, 3813-3825.
41. Kondo, T., Seike, M., Mori, Y., Fujii, K. et al., Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics 2003, 3, 1758-1766.
42. Kondo, T., Hirohashi, S., Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2-D DIGE) for cancer proteomics. Nat. Protoc. 2007, 1, 2940-2956.